Rachel Stauffer - McDermott+Consulting

Overview


Rachel is a highly experienced government relations and legislative affairs strategist and advocate who is informed by a solid foundation of health policy knowledge and years working as a leading health policy aide on Capitol Hill and in the Executive Branch, and as an advisor to a variety of clients.

Prior to joining McDermottPlus, Rachel was the director of government affairs for a leading virtual care company. She led efforts to build the profile of the organization in a fast-moving, innovative policy and regulatory environment encompassing issues related to primary care and behavioral and mental health services provided via virtual care, as well as medical professional licensing, privacy, and security. She also previously served as the director of policy and government relations for a health IT contractor, where she developed the company’s first strategic plan for government relations.

Rachel was previously lead legislative liaison at the US Department of Health and Human Services’ Office of the National Coordinator for Health IT (ONC) where she was instrumental in providing research, analysis and feedback to members of Congress and staff on the 21st Century Cures legislation, among other relevant policies. Rachel also created short- and long-term strategic outreach plans that increased ONC’s visibility and profile.

Earlier in her career, Rachel served in several senior health legislative roles in the personal offices of Members of Congress, including most notably Congresswoman Diana DeGette. She was the primary staff for a variety of health policy issues, including diabetes, medical research, drug and medical device development, data sharing and privacy, mental health and health IT policy, and was a lead staff person creating and driving the 21st Century Cures Act. In these roles, Rachel engaged with many external stakeholders to advance legislative and regulatory challenges and coordinate action on items such as legislation, hearings, briefings and letters to congressional leadership and the administration.

Education


  • George Washington University, M.P.P.
  • New York University, B.A.

Representative Experience


  • Served as lead health policy staff for several Members of Congress, with a focus on advancing legislative priorities through key alliances with other members and relationships with external stakeholders
  • Led several strategic planning efforts focusing on building and maintaining relationships with members and staff in order to increase profiles and presence on Capitol Hill and serve as authoritative sources on related health policy
  • Identified unique and targeted policy opportunities for clients, including navigating the unprecedented federal regulatory and financial support related to pandemic relief.
  • Co-founded a coalition of like-minded telehealth stakeholders including health systems, technology companies, health specialists and primary care providers to advocate for and advance shared policy goals.

Insights and In the News


Healthcare Extenders in an Election Year (March 2024 Update)

McDermott+Consulting Announces Promotions

ONC's HTI-1 Final Rule Adopts New Health IT Certification Requirements

Health Policy Outlook for 2024

New ONC Final Rule Expands Information Blocking Regulatory Exceptions

Pharmacy Benefit Manager Reform: What’s on the Horizon? (December 2023 Update)

HHS Issues Provider Information Blocking Disincentives Proposed Rule

CMS Releases CY 2024 Physician Fee Schedule Final Rule

Landmark Executive Order on AI: What Does It Mean for Healthcare?

Laboratory-Developed Tests: FDA Publishes Highly Anticipated Proposed Rule

A Look into House Efforts on Hospital and Health Plan Price Transparency

CMS Releases CY 2024 Physician Fee Schedule Proposed Rule

Short-Term, Limited Duration Insurance: How Long Is Too Long?

CMS Withdraws COVID-19 Vaccination Mandate, Enhances Focus on Quality Measures

Teleprescribing of Controlled Substances Temporarily Extended Beyond PHE – What's Next?

CMS Unwinds Waivers as the COVID-19 PHE Comes to an End

Federal Government to Wind Down Vaccination Mandates

President’s FY 2024 Budget: HHS Highlights

DEA Proposes Limited Post-PHE Telemedicine Prescription of Controlled Substances

2023 Health Policy Outlook

2023 Consolidated Appropriations Act Extends Select Telehealth Flexibilities

Omnibus Bill Extends Medicare Telehealth Flexibilities and HDHP Telehealth Safe Harbor

Consolidated Appropriations Act, 2023: Health Provisions

Drugmakers Seek Prolonged Shield From Medicare Price Negotiation

Lame Duck Preview 2022

Medicare Drug Price Negotiation Program and Drug Pricing Reform: Eligible Drugs to ...

Corporate America Sees Opportunity in Health Care, but Needs an Assist from ...

Telehealth: “Should I Stay or Should I Go…?”

Impact of Emergency Declarations on CMS Waivers

President’s FY 2023 Budget: HHS Highlights

Senior Director Rachel Stauffer Returns to McDermott+Consulting

Omnibus Spending Package Extends Select Telehealth Flexibilities

Show More

Rachel Stauffer

Insights & Events / Media

No results using the selected filter(s)